Xenon Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -0.15%63.111.0%$460.34m
AMGNAmgen, Inc. 0.21%241.011.3%$449.48m
BIIBBiogen, Inc. -0.11%285.821.4%$388.62m
ILMNIllumina, Inc. -0.48%324.413.5%$318.99m
VRTXVertex Pharmaceuticals, Inc. -1.01%233.131.9%$297.07m
REGNRegeneron Pharmaceuticals, Inc. -0.60%383.262.6%$228.49m
EXASEXACT Sciences Corp. -0.38%89.4424.0%$203.61m
ALXNAlexion Pharmaceuticals, Inc. 1.35%114.032.0%$196.50m
ITCIIntra-Cellular Therapies, Inc. 0.68%26.819.0%$176.98m
INCYIncyte Corp. -0.17%80.492.5%$149.12m
SRPTSarepta Therapeutics, Inc. -1.54%128.3014.6%$142.91m
ARWRArrowhead Pharmaceuticals, Inc. -0.75%56.6811.4%$132.47m
SGENSeattle Genetics, Inc. 1.09%108.836.1%$126.79m
BMRNBioMarin Pharmaceutical, Inc. -0.79%88.434.3%$108.42m
AAgilent Technologies, Inc. 0.66%90.051.6%$106.41m

Company Profile

Xenon Pharmaceuticals, Inc. engages in discovering and developing therapeutics to improve the lives of patients with neurological disorders. It focuses on the treatment of epilepsy. Its products include XEN496, XEN1101, XEN901, and XEN007. The company was founded by Simon Neil Pimstone, Johannes J. P. Kastelein, and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.